Jubilant DraxImage Files Citizen Petition with the Food and Drug Administration (FDA)

Jubilant DraxImage, Inc., a Jubilant Pharma Company, announced today that it filed a citizen petition on April 20, 2015 with the United States federal Food and Drug Administration (FDA) under docket number FDA-2015-p-1296 at http://www.regulations.gov/#!documentDetail;D=FDA-2015-P-1296-0001. The citizen petition is a mechanism used to request, among other things, that the FDA take administrative action. Once a citizen petition is filed, interested parties can submit comments to the FDA for review.

About Jubilant DraxImage, Inc.

At Jubilant DraxImage, we are passionately dedicated to the field of Nuclear Medicine. We focus our efforts to improve quality, safety and sustainability. Our mission is to discover, develop, manufacture and market innovative diagnostic and therapeutic radiopharmaceuticals and other technologies used in our field of expertise. Through our ongoing support of the Nuclear Medicine community, we strive to accelerate, simplify and guide patient management.